Janus Henderson Group PLC Day One Biopharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,839,269 shares of DAWN stock, worth $29.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,839,269

Previous 2,032,384 9.5%

Holding current value

$29.2 Million

Previous $33.6 Million 24.51%

% of portfolio

0.01%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.03 - $17.69 $2.32 Million - $3.42 Million	-193,115 Reduced 9.5%	1,839,269 $25.3 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $17.46 $4.56 Million - $5.87 Million	336,281 Added 19.83%	2,032,384 $33.6 Million
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $8.47 Million - $13.4 Million	874,650 Added 106.48%	1,696,103 $24.8 Million
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $1.5 Million - $1.99 Million	133,943 Added 19.48%	821,453 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $1.46 Million - $1.8 Million	124,716 Added 22.16%	687,510 $8.21 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $7.18 Million - $13.2 Million	562,794 New	562,794 $7.52 Million
Q2 2022 Aug 15, 2022	SELL	$5.72 - $17.9 $5.16 Million - $16.1 Million	-902,020 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.12 - $17.47 $1.1 Million - $2.11 Million	-120,528 Reduced 11.79%	902,020 $8.95 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $1,017 - $1,711	65 Added 0.01%	1,022,548 $16.6 Million
Q3 2021 Nov 16, 2021	SELL	$20.0 - $27.92 $5.51 Million - $7.69 Million	-275,287 Reduced 21.21%	1,022,483 $23.4 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $24.7 Million - $30.7 Million	1,297,770 New	1,297,770 $27.9 Million

Others Institutions Holding DAWN

# of Institutions

170

Shares Held

73.2M

Call Options Held

193K

Put Options Held

213K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.17B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Day One Biopharmaceuticals, Inc. Transaction History